About Vitamin Shoppe (NYSE:VSI)
Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats. The direct segment sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com. The manufacturing segment provides custom manufacturing and private labeling of vitamin, mineral and supplement products, and develops and markets its own branded products for both sales to third parties and for the VSI product assortment. As of December 31, 2016, it marketed approximately 900 brands, as well as its own brands. As of December 31, 2016, it operated 775 stores located in 45 states, the District of Columbia and Puerto Rico, primarily located in retail centers and standalone locations.
Industry, Sector and Symbol:
- Sector: Retail/Wholesale
- Industry: Health Food Stores
- Sub-Industry: Specialty Stores
- Symbol: NYSE:VSI
- CUSIP: 92849E10
- Web: www.vitaminshoppe.com
Capitalization:- Market Cap: $127.28 million
- Outstanding Shares: 23,223,000
Average Prices:- 50 Day Moving Avg: $5.37
- 200 Day Moving Avg: $10.53
- 52 Week Range: $4.95 - $28.33
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 7.46
- P/E Growth: -0.21
Sales & Book Value:- Annual Revenue: $1.24 billion
- Price / Sales: 0.10
- Book Value: $12.73 per share
- Price / Book: 0.40
Profitability:- EBITDA: $99.96 million
- Net Margins: -11.98%
- Return on Equity: 8.33%
- Return on Assets: 4.92%
Debt:- Debt-to-Equity Ratio: 0.42%
- Current Ratio: 2.27%
- Quick Ratio: 0.34%
Misc:- Average Volume: 730,825 shs.
- Beta: 0.75
- Short Ratio: 11.37
Frequently Asked Questions for Vitamin Shoppe (NYSE:VSI)
What is Vitamin Shoppe's stock symbol?
Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."
How were Vitamin Shoppe's earnings last quarter?
Vitamin Shoppe, Inc (NYSE:VSI) posted its earnings results on Wednesday, August, 9th. The company reported $0.23 earnings per share for the quarter, missing analysts' consensus estimates of $0.39 by $0.16. The business earned $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business's quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.55 earnings per share. View Vitamin Shoppe's Earnings History.
When will Vitamin Shoppe make its next earnings announcement?
Where is Vitamin Shoppe's stock going? Where will Vitamin Shoppe's stock price be in 2017?
7 equities research analysts have issued 1 year price objectives for Vitamin Shoppe's stock. Their predictions range from $5.00 to $28.00. On average, they anticipate Vitamin Shoppe's stock price to reach $9.92 in the next twelve months. View Analyst Ratings for Vitamin Shoppe.
Who are some of Vitamin Shoppe's key competitors?
Some companies that are related to Vitamin Shoppe include Zoe's Kitchen (ZOES), Tecnoglass (TGLS), Boot Barn Holdings (BOOT), Fred's (FRED), Kirkland's (KIRK), Sportsman's Warehouse Holdings (SPWH), Noodles & Company (NDLS), Big 5 Sporting Goods Corporation (BGFV), Ruby Tuesday (RT), Build-A-Bear Workshop (BBW), Tuesday Morning Corp. (TUES), Jamba (JMBA), New York & Company (NWY), Natural Grocers by Vitamin Cottage (NGVC), Travelzoo (TZOO), U.S. Auto Parts Network (PRTS), Destination XL Group (DXLG) and Papa Murphy's Holdings (FRSH).
Who are Vitamin Shoppe's key executives?
Vitamin Shoppe's management team includes the folowing people:
- Colin Frederick Watts, Chief Executive Officer, Director
- Brenda M. Galgano CPA, Chief Financial Officer, Executive Vice President
- Michael A. Jaffe, Interim General Counsel, Corporate Secretary
- John D. Bowlin, Lead Independnt Director
- B. Michael Michael Becker CPA, Independent Director
- Deborah M. Derby, Independent Director
- Tracy Dolgin, Independent Director
- David H. Edwab CPA, Independent Director
Who owns Vitamin Shoppe stock?
Vitamin Shoppe's stock is owned by many different of retail and institutional investors. Top institutional investors include
CARLSON CAPITAL L P
(4.97%) and
EAGLE ASSET MANAGEMENT INC
(1.41%). Company insiders that own Vitamin Shoppe stock include B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin and Richard L Markee. View Institutional Ownership Trends for Vitamin Shoppe.
How do I buy Vitamin Shoppe stock?
Shares of Vitamin Shoppe can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vitamin Shoppe's stock price today?
One share of Vitamin Shoppe stock can currently be purchased for approximately $5.15.
MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Vitamin Shoppe (NYSE:VSI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Sell Ratings, 5 Hold Ratings |
| Consensus Rating: | Hold (Score: 1.71) |
| Consensus Price Target: | $9.92 (92.56% upside) |
Consensus Price Target History for Vitamin Shoppe (NYSE:VSI)
Analysts' Ratings History for Vitamin Shoppe (NYSE:VSI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/2/2017 | Morgan Stanley | Reiterated Rating | Equal -> Equal Weight | $8.00 -> $7.50 | High |  |
| 8/23/2017 | Bank of America Corporation | Reiterated Rating | Underperform | $5.50 -> $5.00 | Low | |
| 8/10/2017 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Sell | $13.00 -> $6.00 | Medium | |
| 8/10/2017 | Deutsche Bank AG | Reiterated Rating | Hold | $14.00 -> $7.00 | High | |
| 8/10/2017 | Barclays PLC | Lower Price Target | Equal Weight | $13.00 -> $6.00 | High | |
| 5/11/2017 | Gabelli | Downgrade | Buy -> Hold | | Medium | |
| 10/27/2016 | J P Morgan Chase & Co | Downgrade | Overweight -> Neutral | $33.00 -> $28.00 | N/A | |
| 9/26/2016 | Jefferies Group LLC | Reiterated Rating | Hold | $28.00 | N/A | |
| 8/3/2016 | Wedbush | Reiterated Rating | Outperform | $39.00 | N/A | |
| 5/16/2016 | Robert W. Baird | Reiterated Rating | Hold | | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Neutral | | N/A | |
| 5/5/2016 | Macquarie | Reiterated Rating | Neutral | $40.00 | N/A | |
| 4/15/2016 | Piper Jaffray Companies | Reiterated Rating | Neutral | $30.00 | N/A | |
| 3/28/2016 | William Blair | Downgrade | Market Perform | | N/A | |
(Data available from 10/24/2015 forward)
Earnings History for Vitamin Shoppe (NYSE:VSI)Earnings History by Quarter for Vitamin Shoppe (NYSE VSI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/31/2017 | | $0.18 | | | | | N/A | |
| 8/9/2017 | Q2 2017 | $0.39 | $0.23 | $314.74 million | $304.84 million | View | Listen | |
| 5/10/2017 | Q1 2017 | $0.58 | $0.37 | $325.71 million | $316.90 million | View | N/A | |
| 3/1/2017 | Q416 | $0.40 | $0.36 | $311.79 million | $304.87 million | View | Listen | |
| 11/2/2016 | Q316 | $0.50 | $0.50 | $317.18 million | $314.90 million | View | N/A | |
| 8/3/2016 | Q216 | $0.59 | $0.55 | $331.58 million | $332.70 million | View | N/A | |
| 5/4/2016 | Q116 | $0.65 | $0.67 | $339.76 million | $336.80 million | View | N/A | |
| 2/23/2016 | Q415 | $0.38 | $0.39 | $294.17 million | $293.50 million | View | Listen | |
| 11/4/2015 | Q315 | $0.47 | $0.52 | $317.28 million | $313.90 million | View | N/A | |
| 8/5/2015 | Q215 | $0.54 | $0.57 | $325.78 million | $322.30 million | View | N/A | |
| 5/6/2015 | Q115 | $0.74 | $0.63 | $344.66 million | $336.80 million | View | N/A | |
| 2/24/2015 | Q414 | $0.41 | $0.41 | $294.77 million | $290.10 million | View | N/A | |
| 11/4/2014 | Q314 | $0.52 | $0.40 | $314.60 million | $308.90 million | View | N/A | |
| 8/5/2014 | Q214 | $0.63 | $0.62 | $306.09 million | $306.20 million | View | N/A | |
| 5/7/2014 | Q114 | $0.68 | $0.67 | $302.82 million | $307.80 million | View | N/A | |
| 2/25/2014 | Q413 | $0.38 | $0.37 | $253.87 million | $256.40 million | View | N/A | |
| 11/5/2013 | Q313 | $0.52 | $0.53 | $273.87 million | $272.50 million | View | N/A | |
| 8/6/2013 | Q2 2013 | $0.60 | $0.60 | $284.28 million | $279.50 million | View | Listen | |
| 5/7/2013 | Q1 2013 | $0.69 | $0.68 | $282.71 million | $279.10 million | View | Listen | |
| 2/26/2013 | Q4 2012 | $0.40 | $0.40 | $223.88 million | $218.90 million | View | Listen | |
| 11/6/2012 | Q312 | $0.46 | $0.54 | $234.66 million | $239.00 million | View | N/A | |
| 8/7/2012 | | $0.51 | $0.55 | | | View | N/A | |
| 5/8/2012 | | $0.57 | $0.61 | | | View | N/A | |
| 2/28/2012 | | $0.32 | $0.38 | | | View | N/A | |
| 10/26/2011 | | $0.33 | $0.41 | | | View | N/A | |
| 7/28/2011 | | $0.38 | $0.40 | | | View | N/A | |
| 4/26/2011 | | $0.40 | $0.47 | | | View | N/A | |
| 2/16/2011 | | $0.21 | $0.22 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Vitamin Shoppe (NYSE:VSI)2017 EPS Consensus Estimate: $2.40
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.75 | $0.79 | $0.77 |
| Q2 2017 | 2 | $0.59 | $0.64 | $0.62 |
| Q3 2017 | 2 | $0.53 | $0.57 | $0.55 |
| Q4 2017 | 2 | $0.43 | $0.50 | $0.47 |
(Data provided by Zacks Investment Research)
Dividend History for Vitamin Shoppe (NYSE:VSI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Vitamin Shoppe (NYSE:VSI)Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 98.39%
Insider Trades by Quarter for Vitamin Shoppe (NYSE:VSI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/25/2017 | John D Bowlin | Director | Buy | 40,000 | $5.50 | $220,000.00 | |
| 3/8/2017 | B. Michael Becker | Director | Sell | 2,729 | $19.41 | $52,969.89 | |
| 3/3/2017 | Dan Lamadrid | CAO | Sell | 5,432 | $22.36 | $121,459.52 | |
| 3/3/2017 | Richard L Markee | Director | Sell | 100,000 | $22.24 | $2,224,000.00 | |
| 11/8/2016 | Dan Lamadrid | CAO | Sell | 1,734 | $23.20 | $40,228.80 | |
| 5/31/2016 | Guillermo Marmol | Director | Buy | 1,000 | $30.23 | $30,230.00 | |
| 11/14/2014 | Brenda Galgano | CFO | Sell | 5,000 | $48.77 | $243,850.00 | |
| 11/13/2014 | Richard L Markee | Insider | Sell | 27,774 | $47.79 | $1,327,319.46 | |
| 9/18/2014 | Anthony N Truesdale | CEO | Sell | 61,792 | $45.00 | $2,780,640.00 | |
| 9/18/2014 | Richard L Markee | Insider | Sell | 30,000 | $45.00 | $1,350,000.00 | |
| 9/12/2014 | Jean W Frydman | Insider | Sell | 1,135 | $43.40 | $49,259.00 | |
| 6/16/2014 | Richard L Markee | Chairman | Sell | 10,000 | $45.00 | $450,000.00 | |
| 6/11/2014 | Anthony Alfonso | Insider | Buy | 5,000 | $44.44 | $222,200.00 | |
| 5/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.18 | $1,651,300.00 | |
| 5/1/2014 | Richard Markee | Chairman | Sell | 10,000 | $47.18 | $471,800.00 | |
| 4/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.91 | $1,676,850.00 | |
| 4/1/2014 | Richard Markee | Insider | Sell | 10,000 | $47.91 | $479,100.00 | |
| 3/3/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $46.30 | $1,620,500.00 | |
| 3/3/2014 | Richard Markee | Insider | Sell | 10,000 | $46.29 | $462,900.00 | |
| 1/10/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $48.51 | $1,697,850.00 | |
| 11/14/2013 | Richard Markee | Chairman | Sell | 50,000 | $52.48 | $2,624,000.00 | |
| 11/13/2013 | David Edwab | Director | Sell | 3,738 | $52.35 | $195,684.30 | |
| 2/28/2013 | B. Michael Becker | Director | Buy | 1,000 | $51.95 | $51,950.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Vitamin Shoppe (NYSE:VSI)
Latest Headlines for Vitamin Shoppe (NYSE:VSI)
| Source: |
|
Loading headlines, please wait.
Vitamin Shoppe (VSI) Chart for Tuesday, October, 24, 2017
